Bioretec Accelerates Development of RemeOs Interbody Cage

Bioretec RemeOs Interbody Spinal Cage

Bioretec will accelerate product development of the RemeOs Spinal Interbody Cage, based on an evaluation following receipt of Breakthrough Device Designation in March 2024.

The device is engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy (US Patent No....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0